YHLO (EST. 2008) is an innovative and steadfastly growing IVD company headquartered in Shenzhen, China, specilized in immunoassays solution. (SSE STAR: 688575)
November is the time to be thankful, a time to remember, and to embrace those who enrich our lives. YHLO thanks you for trusting and supporting us. May the good things of life be yours in abundance, not only at Thanksgiving but throughout the coming year.
#Thanksgiving2021
October 13, 2021, Shenzhen, China, YHLO grandly showed up at the China International Medical Equipment Fair(CMEF), brought another new high-end product iFlash 9000 to the spotlight.
#CMEF#YHLO
World Arthritis Day 12 October 2021: Don’t Delay, Healthy Every Day
YHLO provides one-stop RA screening for early diagnosis and timely treatment to prevent future problems.
YHLO initiates win-win cooperation with Beckman Coulter——In August 2021, the first integration of YHLO iModules system with Beckman Coulter Power Express clinical lab automation systems was perfectly installed in Lvliang City People's Hospital, Shanxi Province, China.
On July 15, 2021, the corner stone laying ceremony of Qide Building, the second biopark of YHLO, was grandly held in Longgang District, Shenzhen. The brand new YHLO Biopark II covers an area of 18,010.18 ㎡ and has a total construction area of nearly 110,000 ㎡.
Congratulations! YHLO relocated, a new start to excellence!
As YHLO grows, the International Business Unit and Instrument R&D Center of YHLO relocated to an upgraded, spacious and commodious office within Shenzhen Wisdom Plaza on June 19, 2021.
As we waved goodbye to the Year of the Rat, the Year of the Ox is welcomed in traditional style with reunion dinner, red pockets and firecrackers.🧧🏮
We would take this opportunity to wish you joys and prosperity. Happy Spring Festival!
#ChineseNewYear#LunarNewYear
#WorldCancerDay is commemorated each year on 4 February. #YHLO offers comprehensive tumor markers portfolio relied on superior iFlash1800/3000 chemiluminescence analyzer as below:
PGI, PGII, AFP, CEA, CA125, CA15-3, CA19-9, Free PSA, Total PSA, CYFRA 21-1, NSE
#IAmAndIWill
Assunta Hospital is a community hospital in Malaysia, which is technologically advanced to meet and empower with a panel of over 100 commendable specialists.
With the help of #YHLO Vision ESR analyzer, the efficiency in segmentation diagnostic have been greatly improved.
With our strong social responsibilities in mind, YHLO offers a series of SARS-CoV-2 antigen test products across iFlash-CLIA, UNICELL-FIA, and GLINE-CG platforms to meet the demand of global COVID-19 diagnosis.
Watch the animated video to learn more: https://t.co/lhgJ9sWiaT
#YHLO iFlash 1800 chemiluminescence Immunoassay Analyzer was installed in Rigshospitalet officially in April,2020, mainly for the SARS-CoV-2 antibody and antigen tests. The professional users are highly satisfied with the performance of this instrument.
YHLO’s iModules Integration System for Immunoassay was installed in PUMCH and it made PUMCH was the first to realize a fully automated assembly line among all Chinese top hospitals.
Read More:
https://t.co/WyMo6GXgT0